Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-5c6d5d7d68-thh2z Total loading time: 0 Render date: 2024-08-08T16:25:59.921Z Has data issue: false hasContentIssue false

5 - Myopathies

from Section 2 - Musculoskeletal disorders

Published online by Cambridge University Press:  19 October 2009

By
Chantal Crochetiere
Edited by
David R. Gambling ,
M. Joanne Douglas  and
Robert S. F. McKay
Chantal Crochetiere
Affiliation:
Assistant Professor, University of Montréal, Department of Anesthesiology, Sainte-Justine Hospital, chemin Côte-Ste-Catherine, Montréal, QC, Canada
David R. Gambling
Affiliation:
University of California, San Diego
M. Joanne Douglas
Affiliation:
University of British Columbia, Vancouver
Robert S. F. McKay
Affiliation:
University of Kansas
Get access

Summary

Introduction

Myopathies are diseases of the skeletal muscle cell with intact innervation. The hereditary myopathies are the muscular dystrophies, congenital myopathies, metabolic myopathies, inflammatory myopathies, and disorders of muscle membrane excitability. Pregnant women with a myopathy have specific needs depending on the symptoms and severity of the disease. Exacerbation of muscle weakness is common, especially in the third trimester. This decreased muscle strength may not be able to compensate for the high demands of labor and delivery. Pregnancy may occasionally uncover a disease that was previously asymptomatic. Multidisciplinary consultation early in the pregnancy is important for a successful outcome.

Hereditary myopathies (see Table 5.1)

Muscular dystrophy

Muscular dystrophy is a major cause of progressive weakness and wasting of the musculature of the limbs and trunk. It usually can be differentiated from a neuropathy by the involvement of the proximal muscle, the absence of sensory disturbances, and abnormalities of the electromyogram, muscle biopsy, and DNA studies. Muscular dystrophies are the result of a primary genetic defect, which is specific to each type. Inheritance is due to a dominant, a recessive, or a sex-linked gene, or a muscular dystrophy may arise by the occurrence of a mutation. Classification is based on historic descriptions or clinical similarities. Since oculopharyngeal dystrophy has an onset in the fifth or sixth decade it will not be discussed here.

Duchenne, Becker, and Emery-Dreifuss muscular dystrophies

Duchenne, Becker, and Emery-Dreifuss muscular dystrophies are sex-linked disorders affecting males and they are now classified as dystrophinopathies.

Type
Chapter
Information
Obstetric Anesthesia and Uncommon Disorders , pp. 101 - 114
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brown, R. H. & Mendell, J. R. Muscular dystrophies and other muscle diseases. In Braunwald, E., Fauci, A. S., Kasper, D. L.et al. (eds.), Harrison's Principles of Internal Medicine, 15th edn. New York: McGraw-Hill, 2004, pp. 2529–40.
Dubowitz, V. The muscular dystrophies. In Dubowitz, V. (ed.), Muscle Disorders in Childhood, 2nd edn. London: W B Saunders Co, 1995; pp. 34–133.
Harper, P. S. The differential diagnosis of myotonic dystrophy: other dystrophies and myotonic disorders. In Harper, P. S. (ed.), Myotonic Dystrophy, 2nd edn. London: W B Saunders Co, 1989; pp. 37–78.
Barkhaus, P. E. & Gilchrist, J. M.Duchenne muscular dystrophy manifesting carriers. Arch. Neurol. 1989; 46: 673–5.Google Scholar
Grain, L., Cortina-Borja, M., Forfar, C.et al. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and contrals. Neuromuscular Disorders 2001; 11: 186–91.Google Scholar
Boylan, K.Duchenne muscular dystrophy manifesting carriers (letter). Arch. Neurol. 1990; 47: 951.Google Scholar
Stoelting, R. K. Skin and musculoskeletal diseases. In Stoelting, R. K. & Dierdorf, S. F. (eds.), Anesthesia and Co-existing Disease, 4th edn. New York: Churchill Livingston Inc, 2002; pp. 505–49.
Harper, P. S. Muscle pathology in myotonic dystrophy. In Harper, P. S. (ed.), Myotonic Dystrophy, 2nd edn. London: W B Saunders Co, 1989; pp. 227–50.
Harper, P. S. The genetic basis of myotonic dystrophy. In Harper, P. S. (ed.), Myotonic Dystrophy, 2nd edn. London, W B Saunders Co, 1989; pp. 293–322.
Speedy, H.Exaggerated physiological responses to propofol in myotonic dystrophy. Br. J. Anaesth. 1990; 64: 110–12.Google Scholar
Jaffe, R., Mock, M., Abramowicz, J. & Ben-Aderet, N.Myotonic dystrophy and pregnancy: a review. Obstet. Gynecol. Surv. 1986; 41: 272–8.Google Scholar
Sun, S. F., Binder, J., Streib, E. & Goodlin, R. C.Myotonic dystrophy: obstetric and neonatal complications. South. Med. J. 1985; 78: 823–6.Google Scholar
O'Brien, T., Harper, P. S. & Newcombe, R. G.Blood pressure and myotonic dystrophy. Clinical Genetics 1983; 23: 422–6.Google Scholar
Brunner, H. G., Hamel, B. C., Rieu, P. & Höweler, C. J.Intestinal pseudo-obstruction in myotonic dystrophy. J. Med. Genet. 1992; 29: 791–3.Google Scholar
Finsterer, J. & Stöllberger, C.Cardiac involvement in primary myopathies. Cardiology 2000; 94: 1–11.Google Scholar
Freeman, R. M.Placenta accreta and myotonic dystrophy. Two case reports. Br. J. Obstet. Gynaecol. 1991; 98: 594–5.Google Scholar
Paris, G., Laframboise, R. & Bouchard, J.-P.La mère et l'enfant atteints de dystrophie myotonique de Steinert. Can. J. Neurol. Sci. 1989; 16: 104–8.Google Scholar
Chung, H. T., Tam, A. Y. C., Wong, V.et al. Dystrophia myotonica and pregnancy – an instructive case. Postgrad. Med. J. 1987; 63: 555–7.Google Scholar
Fossen, D. & Gjerstad, L.Obstetric complications as the first sign of myotonic dystrophy. Case report. Acta. Obstet. Gynecol. Scand. 1986; 65: 667–8.Google Scholar
Arulkumaran, S., Rauff, M., Ingemarsson, I. & Gibb, D. M. F.Uterine activity in myotonia dystrophica. Case report. Br. J. Obstet. Gynaecol. 1986; 93: 634–6.Google Scholar
Walpole, A. R. & Ross, A. W.Acute cord prolapse in an obstetric patient with myotonia dystrophica. Anaesth. Intens. Care 1992; 20: 526–8.Google Scholar
Gilchrist, J. M. Muscle disease in the pregnant woman. In Devinsky, O., Feldmann, E. & Hainline, B. (eds.), Neurological Complications of Pregnancy, New York: Raven Press Ltd, 1994; pp. 193–208.
Harper, P. S. Endocrine abnormalities in myotonic dystrophy. In Harper, P. S. (ed.), Myotonic Dystrophy, 2nd edn. London: W B Saunders Co, 1989; pp. 121–48.
Sarnat, H. B., O'Connor, T. & Byrne, P. A.Clinical effects of myotonic dystrophy on pregnancy and the neonate. Arch. Neurol. 1976; 33: 459–65.Google Scholar
Sciarra, J. J. & Steer, C. M.Uterine contractions during labor in myotonic muscular dystrophy. Am. J. Obstet. Gynecol. 1961; 82: 612–15.Google Scholar
Bray, R. J. & Inkster, J. S.Anaesthesia in babies with congenital dystrophia myotonica. Anaesthesia 1984; 39: 1007–11.Google Scholar
Tsatsaris, V., Papatsonis, D., Goffinet, F., Dekker, G. & Carbonne, B.Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obst. Gynecol. 2001; 97: 840–7.Google Scholar
Stoelting, R. K. & Hillier, S. C.Pharmacology and Physiology in Anesthetic Practice, 4th edn. Philadelphia, PA: Lippincott Williams and Wilkins, 2006, p. 392.
Roizen, M. F. Anesthetic implications of concurrent diseases. In Miller, R. D. (ed.), Anesthesia, 4th edn. New York: Livingstone, 1994, p. 990.
Zalman, F., Perloff, J. K., Durant, N. N. & Campion, D. S.Acute respiratory failure following intravenous verapamil in Duchennes's muscular dystrophy. Am. Heart J. 1983; 105: 510–11.Google Scholar
Hageman, A. T. M., Gabreëls, F. J., Liem, K. D., Renkawek, K. & Boon, J. M.Congenital myotonic dystrophy; a report on thirteen cases and a review of the literature. J. Neurol. Sci. 1993; 115: 95–101.Google Scholar
Harper, P. S. & Dyken, P. R.Early-onset dystrophia myotonica. Evidence supporting a maternal environmental factor. Lancet 1972; 2: 53–5.Google Scholar
Koch, M. C., Grimm, T., Harley, H. G. & Harper, P. S.Genetic risks for children of women with myotonic dystrophy. Am. J. Hum. Genet. 1991; 48: 1084–91.Google Scholar
Andrews, P. I. & Wilson, J.Relative disease severity in siblings with myotonic dystrophy. J. Child. Neurol. 1992; 7: 161–7.Google Scholar
Levine, A. B., Eddleman, K. A., Chitkara, U.et al. Congenital myotonic dystrophy: an often unsuspected cause of severe polyhydramnios. Prenat. Diagn. 1991; 11: 111–15.Google Scholar
Afifi, A. M., Bhatia, A. R. & Eyal, F.Hydrops fetalis associated with congenital myotonic dystrophy. Am. J. Obstet. Gynecol. 1992; 166: 929–30.Google Scholar
Stratton, R. F. & Patterson, R. M.DNA confirmation of congenital myotonic dystrophy in non-immune hydrops fetalis. Prenat. Diagn. 1993; 13: 1027–30.Google Scholar
Wesström, G., Bensch, J. & Shollin, J.Congenital myotonic dystrophy. Incidence, clinical aspects and early prognosis. Acta. Paediatr. Scand. 1986; 75: 849–54.Google Scholar
Harper, P. S. Myotonic dystrophy in infancy and childhood. In Harper, P. S. (ed.), Myotonic Dystrophy, London: W B Saunders Co, 1989; pp. 187–225.
Buxton, J., Shelbourne, P., Davies, J.et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992; 355: 547–8.Google Scholar
Mahadevan, M., Tsilfidis, C., Sabourin, L.et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 1992; 255: 1253–5.Google Scholar
Tsilfidis, C., MacKenzie, A. E., Mettler, G., Barcelo, J. & Kornelok, R. G.Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat. Genet. 1992; 1: 192–5.Google Scholar
Hook, R., Anderson, E. F. & Noto, P.Anesthetic management of a parturient with myotonia atrophica. Anesthesiology 1975; 43: 689–92.Google Scholar
Wheeler, A. S., James, F. M., 3rd. Local anesthesia for laparoscopy in a case of myotonia dystrophica. Anesthesiology 1979; 50: 169.Google Scholar
Harris, M. N. E.Extradural analgesia and dystrophia myotonia. Anaesthesia 1984; 39: 1032.Google Scholar
Paterson, R. A., Tousignant, M. & Skene, D. S.Caesarean section for twins in a patient with myotonic dystrophy. Can. Anaesth. Soc. J. 1985; 32: 418–21.Google Scholar
Cope, D. K. & Miller, J. N.Local and spinal anesthesia for cesarean section in a patient with myotonic dystrophy. Anesth. Analg. 1986; 65: 687–90.Google Scholar
Blumgart, C. H., Hughes, D. G. & Redfern, N.Obstetric anaesthesia in dystrophia myotonica. Anaesthesia 1990; 45: 26–9.Google Scholar
Camann, W. R. & Johnson, M. D.Anesthetic management of a parturient with myotonia dystrophica: a case report. Reg. Anesth. 1990; 15: 41–3.Google Scholar
Stevens, J. D. & Wauchob, T. D.Dystrophia myotonica – emergency caesarean section with spinal anaesthesia. Eur. J. Anaesthesiol. 1991; 8: 305–8.Google Scholar
Campbell, A. M. & Thompson, N.Anaesthesia for Caesarean section in a patient with myotonic dystrophy receiving warfarin therapy. Can. J. Anaesth. 1995; 42: 409–14.Google Scholar
Aldridge, L. M.Anaesthetic problems in myotonic dystrophy. Br. J. Anaesth. 1985; 57: 1119–30.Google Scholar
Harper, P. S. Cardiorespiratory problems. In Harper, P. S. (ed.), Myotonic Dystrophy, London: W B Saunders Co, 1989; pp. 93–120.
Towbin, J. A. & Roberts, R. Cardiovascular diseases due to genetic abnormalities. In Schlant, R. C., Alexander, R. W. & Fuster, V. (eds.), Hurst's the Heart: Arteries and Veins, 9th edn. New York: McGraw-Hill, 1998; pp. 1877–1923.
Phillips, M. P. & Harper, P. S.Cardiac disease in myotonic dystrophy. Cardiovascular Research 1997; 33: 13–22.Google Scholar
Hawley, R. J., Milner, M. R., Gottdiener, J. S. & Cohen, A.Myotonic heart disease: a clinical follow-up. Neurology 1991; 41: 259–62.Google Scholar
Meyers, M. B. & Barash, P. G.Cardiac decompensation during enflurane anesthesia in a patient with myotonia atrophica. Anesth. Analg. 1976; 55: 433–6.Google Scholar
Fall, L. H., Young, W. W., Power, J. A.et al. Severe congestive heart failure and cardiomyopathy as a complication of myotonic dystrophy in pregnancy. Obstet. Gynecol. 1990; 76: 481–4.Google Scholar
Dodds, T. M., Haney, M. F. & Appleton, F. M.Management of peripartum congestive heart failure using continuous arteriovenous hemofiltration in a patient with myotonic dystrophy. Anesthesiology 1991; 75: 907–11.Google Scholar
Miller, J. D. & Rosenbaum, H. Muscle diseases. In Benumof, J. L. (ed.), Anesthesia and Uncommon Diseases, 4th edn. Philadelphia: W B Saunders Co, 1998; pp. 316–97.
Novy, M. J. & Edwards, M. J.Respiratory problems in pregnancy. Am. J. Obstet. Gynecol. 1967; 99: 1024–45.Google Scholar
Müller, H. & Manen, Punt-van J. A.Maxillo-facial deformities in patients with dystrophia myotonica and the anaesthetic implications. J. Maxillofac. Surg. 1982; 10: 224–8.Google Scholar
Bouly, A., Nathan, A. & Feiss, P.Propofol in myotonic dystrophy. Anaesthesia 1991; 46: 705.Google Scholar
O'Connor, P. J., Caldicott, L. D. & Braithwaite, P.Urgent caesarean section in a patient with myotonic dystrophy: a case report and review. Int. J. Obstet. Anesth. 1996; 5: 272–4.Google Scholar
Driver, I. K. & Broadway, J. W.Dystrophia myotonica: combined spinal–epidural anaesthesia for caesarean section. Int. J. Obstet. Anesth. 1996; 5: 275–7.Google Scholar
White, D. A. & Smyth, D. G.Continuous infusion of propofol in dystrophia myotonica. Can. J. Anaesth. 1989; 36: 200–3.Google Scholar
Pollard, B. J. & Young, T. M.Anaesthesia in myotonia dystrophica (letter). Anaesthesia 1989; 44: 699.Google Scholar
Mitchell, M. M., Ali, H. H. & Savarese, J. J.Myotonia and neuromuscular blocking agents. Anesthesiology 1978; 49: 44–8.Google Scholar
Castano, J. & Pares, N.Anaesthesia for major abdominal surgery in a patient with myotonia dystrophica. Br. J. Anaesth. 1987; 59: 1629–31.Google Scholar
Azar, I.The response of patients with neuromuscular disorders to muscle relaxants: a review. Anesthesiology 1984; 61: 173–87.Google Scholar
Buzello, W., Krieg, N. & Schlickewei, A.Hazards of neostigmine in patients with neuromuscular disorders. Report of two cases. Br. J. Anaesth. 1982; 54: 529–34.Google Scholar
Rosenberg, H.Neuromuscular diseases, myopathies and anesthesia. Curr. Rev. Clin. Anesth. 1983; 3: 99–107.Google Scholar
Britt, B. A. & Kalow, W.Malignant hyperthermia: a statistical review. Can. Anaesth. Soc. J. 1970; 17: 293–315.Google Scholar
Brownell, A. K. W.Malignant hyperthermia: relationship to other diseases. Br. J. Anaesth. 1988; 60: 303–8.Google Scholar
Lehmann-Horn, F. & Knorr-Held, S.Muscle diseases relevant to the anaesthetist. Acta Anaesthesiologica Belgica 1990; 41: 113–18.Google Scholar
Wedel, D. J.Review article: malignant hyperthermia and neuromuscular disease. Neuromusc. Disord. 1992; 2: 157–64.Google Scholar
Mudge, B. J., Taylor, P. B. & Vanderspek, A. F.Perioperative hazards in myotonic dystrophy. Anaesthesia 1980; 35: 492–5.Google Scholar
Moore, J. K. & Moore, A. P.Postoperative complications of dystrophia myotonica. Anaesthesia 1987; 42: 529–33.Google Scholar
Branthwaite, M. A.Myotonic dystrophy and respiratory function (letter). Anaesthesia 1990; 45: 250–1.Google Scholar
Duncan, P. G. Neuromuscular diseases. In Katz, J. & Steward, D. J. (eds.), Anesthesia and Uncommon Pediatric Diseases, 2nd edn. Philadelphia: W B Saunders Co, 1993; pp. 672–94.
Munsat, T. L. Facioscapulohumeral dystrophy and the scapuloperoneal syndrome. In Engel, A. G. & Banker, B. Q. (eds.), Myology, Vol. II. New York: McGraw-Hill, 1986; pp. 1251–66.
Baldwin, B. J., Talley, R. C., Johnson, C. & Nutter, D. O.Permanent paralysis of the atrium in a patient with facioscapulohumeral muscular dystrophy. Am. J. Cardiol. 1973; 31: 649–53.Google Scholar
Shields, R. W., Jr. Limb girdle syndromes. In Engel, A. G. & Banker, B. Q. (eds.), Myology, Vol. II. New York: McGraw-Hill, 1986; pp. 1349–65.
Jackson, C. E. & Strehler, D. A.Limb-girdle muscular dystrophy: clinical manifestations and detection of preclinical disease. Pediatrics 1968; 41: 495–502.Google Scholar
Antonio, J. H., Diniz, M. C. & Miranda, D.Persistent atrial standstill with limb-girdle muscular dystrophy. Cardiology 1978; 63: 39–46.Google Scholar
Ville, Y., Barbet, J. P., Pompidou, A. & Tournaire, M.Myopathie des ceintures et grossesse: Un cas. J. Gynecol. Obstet. Biol. Reprod. 1991; 20: 973–7.Google Scholar
Ekblad, U. & Kanto, J.Pregnancy outcome in an extremely small woman with muscular dystrophy and respiratory insufficiency. Acta Anaesthesiol. Scand. 1993; 37: 228–30.Google Scholar
Rudnik-Chöneborn, S., Glauner, B., Röhrig, D. & Zerres, K.Obstetric aspects in women with facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and congenital myopathies. Arch. Neurol. 1997; 54: 888–94.Google Scholar
Banker, B. Q. Congenital muscular dystrophy. In Engel, A. G. & Banker, B. Q. (eds.), Myology, Vol. II. New York: McGraw-Hill, 1986; pp. 1367–82.
Dubowitz, V. The congenital myopathies. In Muscle Disorders in Childhood, 2nd edn. London: W B Saunders Co, 1995; p. 134.
Banker, B. Q. The congenital myopathies. In Engel, A. G. & Banker, B. Q. (eds.), Myology, Vol. II. New York: McGraw-Hill, 1986; pp. 1527–81.
Denborough, M. A., Dennett, X. & Anderson, R. M.Central-core disease and malignant hyperpyrexia. Br. Med. J. 1973; 1: 272–3.Google Scholar
Harriman, D. G. F. & Ellis, F. R.Central-core disease and malignant hyperpyrexia (letter). Br. Med. J. 1973; 1: 545–6.Google Scholar
Otsuka, H., Komura, Y., Mayumi, T.et al. Malignant hyperthermia during sevoflurane anesthesia in a child with central core disease. Anesthesiology 1991; 75: 699–701.Google Scholar
Calore, E. E., Cavaliere, M. J., Perez, N. M.et al. Hyperthermic reaction to haloperidol with rigidity associated to central core disease. Acta Neurologica (Napoli) 1994; 16: 157–61.Google Scholar
Islander, G., Henriksson, K. G. & Ranklev-Twetman, E.Malignant hyperthermia susceptibility without central core disease (CCD) in a family where CCD is diagnosed. Neuromuscul. Disord. 1995; 5: 125–7.Google Scholar
Gordon, C. P. & Litz, S.Multicore myopathy in a patient with anhidrotic ectodermal dysplasia. Can. J. Anaesth. 1992; 39: 966–8.Google Scholar
Heard, S. T. & Kaplan, R. F.Neuromuscular blockade in a patient with nemaline myopathy. Anesthesiology 1983; 59: 588–90.Google Scholar
Cunliffe, M. & Burrows, F. A.Anaesthetic implications of nemaline rod myopathy. Can. Anaesth. Soc. J. 1985; 32: 543–7.Google Scholar
Asai, T., Fujise, K. & Uchida, M.Anaesthesia for cardiac surgery in children with nemaline myopathy. Anaesthesia 1992; 47: 405–8.Google Scholar
Pourmand, R. & Azzarelli, B.Adult-onset of nemaline myopathy associated with cores and abnormal mitochondria. Muscle Nerve 1994; 17: 1218–20.Google Scholar
Stackhouse, R., Chelmow, D. & Dattel, B. J.Anesthetic complications in a pregnant patient with nemaline myopathy. Anesth. Analg. 1994; 79: 1195–7.Google Scholar
Gottschalk, A., Heiman-Patterson, T., , Quevedo R. & Quinn, P. D.General anesthesia for a patient with centronuclear (myotubular) myopathy. Anesthesiology 1998; 89: 1018–20.Google Scholar
Chitayat, D., Hodgkinson, K. A., Ginsburg, O., Dimmick, J. & Watters, G. V.King syndrome: a genetically heterogenous phenotype due to congenital myopathies. A. J. Med. Genet. 1992; 43: 954–6.Google Scholar
Abel, D. E. & Grotegut, C. A.King syndrome in pregnancy. Obstet. Gynecol. 2003; 101 1146–8.Google Scholar
Habib, A. S., Millar, S., Deballi, P., 3rd & Muir, H. A.Anesthetic management of a ventilator-dependent parturient with the King-Deborough syndrome. Can. J. Anesth. 2003; 50: 589–92.Google Scholar
Johnson, M. P., Compton, A., Drugan, A. & Evans, M. I.Metabolic control of Von Gierke disease (glycogen storage disease type 1A) in pregnancy: maintenance of euglycemia with cornstarch. Obstet. Gynecol. 1990; 75: 507–10.Google Scholar
Morgan-Hughes, J. A. The mitochondrial myopathies. In Engel, A. G. & Banker, B. Q. (eds.), Myology, Vol. II. New York: McGraw-Hill, 1986; pp. 1709–43.
Dubowitz, V. Metabolic myopathies II: lipids disorders mitochondrial disorders. In Muscle Disorders in Childhood, 2nd edn. London: W B Saunders Co, 1995; p. 211.
Schapira, A. H.Mitochondrial myopathies: mechanisms now better understood (letter). Br. Med. J. 1989; 298: 1127–8.Google Scholar
Boudin, G., Mikol, J., Guillard, A.et al. Fatal systemic carnitine deficiency with lipid storage in skeletal muscle, heart, liver and kidney. J. Neurol. Sci. 1976; 30: 313–25.Google Scholar
Cornelio, F., Donato, Di S., Peluchetti, D.et al. Fatal cases of lipid storage myopathy with carnitine deficiency. J. Neurol. Neurosurg. Psych. 1977; 40: 170–8.Google Scholar
Angelini, C., Govoni, E., Bragaglia, M. M. & Vergani, L.Carnitine deficiency: acute postpartum crisis. Ann. Neurol. 1978; 4: 558–61.Google Scholar
Rowe, R. W. & Helander, E.Anesthetic management of a patient with systemic carnitine deficiency. Anesth. Analg. 1990; 71: 295–7.Google Scholar
Beilin, B., Shulman, D. & Schiffman, Y.Anaesthesia in myopathy of carnitine deficiency. Anaesthesia 1986; 41: 92.Google Scholar
Katsuya, H., Misumi, M., Ohtani, Y. & Miike, T.Postanesthetic acute renal failure due to carnitine palmityl transferase deficiency. Anesthesiology 1988; 68: 945–8.Google Scholar
Zierz, S. & Schmitt, U.Inhibition of carnitine palmitoyltransferase by Malonyl-CoA in human muscle is influenced by anesthesia. Anesthesiology 1989; 70: 373.Google Scholar
Dreval, D., Bernstein, D. & Zakut, H.Carnitine palmitoyl transferase deficiency in pregnancy. A case report. Am. J. Obstet. Gynecol. 1994; 170: 1390–2.Google Scholar
Bonnefont, J. P., Gemaugre, F., Prip-Buus, C.et al. Carnitine palmitoyltransferase deficiencies. Molecular Genetics and Metabolism 1990; 68: 424–40.Google Scholar
Moundras, J. M., Wattrisse, G., Leroy, B., Decocq, J. & Krivosic-Horber, R.Prise en charge anesthésique du travail obstetrical chez une parturiente atteinte d'un deficit musculaire en carnitine palmitoyl transférase. Ann. Fr. Anesth. Réanim. 2000; 19: 611–16.Google Scholar
Mardirosoff, C., Dumont, L., Cobin, L. & Massaut, J.Labour analgesia in a patient with carnitine palmityl transferase deficiency and idiopathic thrombocytopenic purpura. Int. J. Obst. Anesth. 1997; 7: 134–6.Google Scholar
Stoelting, R. K. & Hillier, S. C.Pharmacology and Physiology in Anesthetic Practice, 4th edn. Philadelphia, PA: Lippincott Williams and Wilkins, 2006, p. 162.
Salengos, J. C., Velghe-Lenelle, C. E., Bollens, R., Engelman, E. & Barvais, L.Lactic acidosis during propofol-remifentanil anesthesia in an adult. Anesthesiology 2004; 101: 241–3.Google Scholar
Berkowitz, K., Monteagudo, A., Marks, F., Jackson, U. & Baxi, L.Mitochondrial myopathy and preeclampsia associated with pregnancy. Am. J. Obstet. Gynecol. 1990; 162: 146.Google Scholar
Roseag, O. P., Morrison, S. & MacLeod, J. P.Clinical report: anaesthetic management of labour and delivery in the parturient with mitochondrial myopathy. Can. J. Anaesth. 1996; 43: 1–5.Google Scholar
Blake, L. L. & Shaw, R. W.Mitochondrial myopathy in a primigravid pregnancy. Br. J. Obstet. Gynaecol. 1999; 106: 871–3.Google Scholar
Russell, S. H. & Hirsch, N. P.Anaesthesia and myotonia. Br. J. Anaesth. 1994; 72: 210–16.Google Scholar
Allen, G. C. Malignant hyperthermia in musculoskeletal disorders. In Kirby, R. R. & Brown, D. L. (eds.), Problems in Anaesthesia, Vol. V, Philadelphia: J P Lippincott Co, 1991; p. 146.
Harper, P. S. Cardiorespiratory problems. In Harper, P. S. (ed.), Myotonic Dystrophy, London: W B Saunders Co, 1989; pp. 93–120.
Heiman-Patterson, T., Martino, C., Rosenberg, H., Fletcher, J. & Tahmoush, A.Malignant hyperthermia in myotonia congenita. Neurology 1988; 38: 810–12.Google Scholar
Haberer, J. P., Fabre, F. & Rose, E.Malignant hyperthermia and myotonia congenital (Thomsen's disease). Anaesthesia 1989; 44: 166.Google Scholar
Lehmann-Horn, F. & Iaizzo, P. A.Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?Br. J. Anaesth. 1990; 65: 692–7.Google Scholar
Lambert, C., Blanloeil, Y., Krivosic Horber, R.et al. Malignant hyperthermia in a patient with hypokalemic periodic paralysis. Anesth. Analg. 1994; 79: 1012–14.Google Scholar
Dubowitz, V. Metabolic myopathies III: ion channel disorders. In Muscle Disorders in Childhood, 2nd edn, London: W B Saunders Co, 1995; pp. 266–314.
Engel, A. G. Periodic paralysis. In Engel, A. G. & Banker, B. Q. (eds.), Myology, Vol. II, New York: McGraw-Hill, 1986; pp. 1843–70.
Bashford, A. C.Case report: anaesthesia in familial hypokalaemic periodic paralysis. Anaesth. Intens. Care 1977; 5: 74–5.Google Scholar
Rooney, R. T., Shanahan, E. C., Sun, T. & Nally, B.Atracurium and hypokalemic familial periodic paralysis. Anesth. Analg. 1988; 67: 782–3.Google Scholar
Fukuda, K., Ogawa, S., Yokozuka, H., Handa, S. & Nakamura, Y.Long-standing bidirectional tachycardia in a patient with hypokalemic periodic paralysis. J. Electrocardiol. 1988; 21: 71.Google Scholar
Lema, G., Urzua, J., Moran, S. & Canessa, A.Successful anesthetic management of a patient with hypokalemic familial periodic paralysis undergoing cardiac surgery. Anesthesiology 1991; 74: 373–5.Google Scholar
Laurito, C. E., Becker, G. L. & Miller, P. E.Atracurium use in a patient with familial periodic paralysis. J. Clin. Anesth. 1991; 3: 225–8.Google Scholar
Neuman, G. G. & Kopman, A. F. P.Dyskalemic periodic paralysis and myotonia. Anesth. Analg. 1993; 76: 426–8.Google Scholar
Viscomi, C. M., Ptacek, L. J. & Dudley, D.Anesthetic management of familial hypokalemic periodic paralysis during parturition. Anesth. Analg. 1999; 88: 1081–2.Google Scholar
Johnstone, F. D. & Greer, I. A.Hyperkalaemic periodic paralysis and HELLP syndrome: an unusual combination. Scot. Med. J. 1989; 34: 530–1.Google Scholar
Aarons, J. J., Moon, R. E. & Camporesi, E. M.General anesthesia and hyperkalemic periodic paralysis. Anesthesiology 1989; 71: 303–4.Google Scholar
Ashwood, E. M., Russell, W. J. & Burrow, D. D.Hyperkalaemic periodic paralysis and anaesthesia. Anaesthesia 1992; 47: 579–84.Google Scholar
Farbu, E., Softeland, E. & Bindoff, L. A.Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders. Acta Anaesthesiol. Scand. 2003; 47: 630–4.Google Scholar
Schwartz, I. L., Dingfelder, J. R., O'Tuama, L. & Swift, M.Recessive congenital myotonia and pregnancy. Int. J. Gynaecol. Obstet. 1979; 17: 194–6.Google Scholar
Ptacek, L. J., Ziter, F. A., Roberts, J. W.et al. Evidence of genetic heterogeneity among the nondystrophic myotonias. Neurology 1992; 42: 1046–8.Google Scholar
Streib, E. W.Paramyotonia congenita. Semin. Neurol. 1991; 11: 249–57.Google Scholar
Silva, S. M., Kuncl, R. W., Griffin, J. W., Cornblath D. R. & Chavoustie, S. Paramyotonia congenita or hyperkalemic periodic paralysis? Clinical and electrophysiological features of each entity in one family. Muscle Nerve 1990; 13: 21–6.Google Scholar
Ptacek, J. J., Tarwil, R., Griggs, R. C., Storvick, M. S. & Leppert, M.Linkage of atypical myotonia to a sodium channel locus. Neurology 1992; 42: 431–3.Google Scholar
Chitayat, D., Etchell, M. & Wilson, R. D.Cold-induced abortion in paramyotonia congenita. Am. J. Obstet. Gynecol. 1988; 158: 435–6.Google Scholar
Howell, P. R. & Douglas, M. J.Lupus anticoagulant, paramyotonia congenita and pregnancy. Can. J. Anaesth. 1992; 39: 992–6.Google Scholar
Grace, R. F. & Roach, V. J.Caesarean section in a patient with paramyotonia congenita. Anaesth. Intensive Care 1999; 27: 534–7.Google Scholar
Catoggio, L. J. & Soriano, E. R.Inflammatory muscle disease: therapeutic aspects. Baillière's Clinical Rheumatology 2000; 14: 55–71.Google Scholar
Kofteridis, D. P., Malliotakis, P. I., Sotsiou, F.et al. Acute onset of dermatomyositis presenting in pregnancy with rhabdomyolysis and fetal loss. Scand. J. Rheumatal. 1999; 28: 192–4.Google Scholar
Dalakas, M. C. Polymyositis dermatomyositis, and inclusion body myositis. In Braunwald, E., Fauci, A. S., Kasper, D. L.et al. (eds.), Harrison's Principles of Internal Medicine, 16th edn. New York: McGraw-Hill, 2005, Chapter 369: pp. 2540–5.
Ishii, N., Ono, H., Kawaguchi, T. & Nakajima, H.Dermatomyositis and pregnancy. Dermatologica 1991; 183: 146–9.Google Scholar
Gda, Pinheiro R., Goldenberg, J., Atra, E.et al. Juvenile dermatomyositis and pregnancy: report and literature review. J. Rheumatol. 1992; 19: 1798–801.Google Scholar
Ohno, R., Imai, A. & Tamaya, T.Successful outcomes of pregnancy complicated with dermatomyositis. Gynecol. Obstet. Invest. 1992; 33: 187–9.Google Scholar
Harris, A., Weblwey, M., Usherwood, M. & Burge, S.Dermatomyositis presenting in pregnancy. British Journal of Dermatology 1995; 133: 782–5.Google Scholar
Brown, S., Shupak, R. C., Patel, C. & Calkins, J. M.Neuromuscular blockade in a patient with active dermatomyositis. Anesthesiology 1992; 77: 1031–3.Google Scholar
Saarnivaara, L. H.Anesthesia for a patient with polymyositis undergoing myectomy of the cricopharyngeal muscle. Anesth. Analg. 1988; 67: 701–2.Google Scholar
Davidson, B. N., Bowerman, R. A. & Ferla, J. J.Myositis ossificans progressiva and pregnancy. A therapeutic dilemma. J. Reprod. Med. 1985; 30: 945–7.Google Scholar
Banker, B. Q. Other inflammatory myopathies. In Engel, A. G. & Banker, B. Q. (eds.), Myology, Vol. II, New York: McGraw-Hill, 1986; pp. 1501–24.
Fox, S., Khoury, A., Mootabar, H. & Greenwald, E. F.Myositis ossificans progressiva and pregnancy. Obstet. Gynecol. 1987; 69: 453–4.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Myopathies
    • By Chantal Crochetiere, Assistant Professor, University of Montréal, Department of Anesthesiology, Sainte-Justine Hospital, chemin Côte-Ste-Catherine, Montréal, QC, Canada
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.006
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Myopathies
    • By Chantal Crochetiere, Assistant Professor, University of Montréal, Department of Anesthesiology, Sainte-Justine Hospital, chemin Côte-Ste-Catherine, Montréal, QC, Canada
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.006
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Myopathies
    • By Chantal Crochetiere, Assistant Professor, University of Montréal, Department of Anesthesiology, Sainte-Justine Hospital, chemin Côte-Ste-Catherine, Montréal, QC, Canada
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.006
Available formats
×